Department of Surgery, University Hospital Düsseldorf, Düsseldorf, Germany.
Liver Int. 2014 Jan;34(1):89-101. doi: 10.1111/liv.12195. Epub 2013 May 23.
The molecular mechanisms of haematopoietic stem cells (HSC) mobilization and homing to the liver after partial hepatectomy (PH) remain largely unexplored.
Functional liver volume loss and regain was determined by computerized tomography (CT) volumetry in 30 patients following PH. Peripheral HSC mobilization was investigated by fluorescence-activated cell sorting (FACS) analyses and cytokine enzyme-linked immunosorbent assay assays. Migration of purified HSC towards hepatic growth factor (HGF) and stroma-derived factor-1 (SDF-1) gradients was tested in vitro. Mice after 70% PH were examined for HSC mobilization by FACS and cytokine mRNA expression in the liver. FACS-sorted HSC were administered after PH and hepatocyte proliferation was evaluated by immunohistochemical staining for Ki67.
Impaired liver function was noted after extended hepatic resection when compared to smaller resections. Patients with large liver resections were characterized by significantly higher levels of peripheral HSC which were positively correlated with the extent of resected liver volume and its regain after 3 weeks. Increased plasma levels of HGF, SDF-1 and insulin like growth factor (IGF-1) were evident within the first 6 hours post resection. Migration assays of human HSC in vitro showed a specific target-demonstrated migration towards recombinant HGF and SDF-1 gradients in a concentration and specific receptor (c-Met and CXCR4) dependent manner. The evaluation of peripheral human alpha foetoprotein expression demonstrated pronounced stemness following increased CD133(+) HSC in the course of liver regeneration following PH. Our human data were further validated in a murine model of PH and furthermore demonstrated increased hepatocyte proliferation subsequent to CD133(+) HSC treatment.
HGF and SDF-1 are required for effective HSC mobilization and homing to the liver after hepatic resection. These findings have significant implications for potential therapeutic strategies targeting chemotactant modulation and stem cell mobilization for liver protection and regeneration.
部分肝切除(PH)后造血干细胞(HSC)动员和归巢到肝脏的分子机制在很大程度上仍未得到探索。
通过计算机断层扫描(CT)体积测量,在 30 例 PH 后患者中确定功能性肝体积损失和恢复情况。通过荧光激活细胞分选(FACS)分析和细胞因子酶联免疫吸附试验(ELISA)检测外周 HSC 动员情况。体外测试纯化 HSC 向肝生长因子(HGF)和基质衍生因子-1(SDF-1)梯度的迁移。通过 FACS 和肝内细胞因子 mRNA 表达检测 70% PH 后小鼠的 HSC 动员情况。PH 后给予 FACS 分选的 HSC,并通过 Ki67 免疫组织化学染色评估肝细胞增殖。
与较小的切除相比,广泛肝切除后肝功能受损。大肝切除患者的外周 HSC 水平明显升高,与切除的肝体积及其术后 3 周的恢复量呈正相关。术后 6 小时内,血浆中 HGF、SDF-1 和胰岛素样生长因子(IGF-1)水平明显升高。体外人 HSC 迁移实验显示,人 HSC 以浓度和特定受体(c-Met 和 CXCR4)依赖性方式特异性靶向重组 HGF 和 SDF-1 梯度迁移。外周人甲胎蛋白表达的评估显示,在 PH 后肝再生过程中,CD133(+) HSC 增加后,表现出明显的干细胞特性。我们的人体数据在 PH 的小鼠模型中得到进一步验证,并进一步证明 CD133(+) HSC 治疗后肝细胞增殖增加。
HGF 和 SDF-1 是 HSC 动员和归巢到肝脏的有效条件。这些发现对潜在的治疗策略具有重要意义,这些策略针对趋化因子调节和干细胞动员,以实现肝保护和再生。